Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Anti-Cancer Drugs
|
July 11, 2003
Heterogeneity of chemosensitivity of esophageal and gastric carcinoma
Stuart J Mercer, Shaw S Somers, Louise A Knight, et al.
Anti-Cancer Drugs
|
August 13, 2002
Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer
Federica Di Nicolantonio, Michael H Neale, Louise A Knight, et al.
Anti-Cancer Drugs
|
October 1, 2004
Ex vivo characterization of XR11576 (MLN576) against ovarian cancer and other solid tumors
Federica Di Nicolantonio, Louise A Knight, Silvana Di Palma, et al.
Anti-Cancer Drugs
|
August 19, 2006
The effect of imatinib mesylate (Glivec) on human tumor-derived cells
Louise A Knight, Federica Di Nicolantonio, Pauline A Whitehouse, et al.
Anti-Cancer Drugs
|
October 1, 2004
Ex vivo reversal of chemoresistance by tariquidar (XR9576)
Federica Di Nicolantonio, Louise A Knight, Sharon Glaysher, et al.
Anti-Cancer Drugs
|
April 23, 2005
Rapid up-regulation of cyclooxygenase-2 by 5-fluorouracil in human solid tumors
Stuart J Mercer, Federica Di Nicolantonio, Louise A Knight, et al.
BMC Cancer
|
July 5, 2003
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
Sanjay Sharma, Michael H Neale, Federica Di Nicolantonio, et al.
BMC Cancer
|
August 29, 2009
Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)
Sharon Glaysher, Dennis Yiannakis, Francis G Gabriel, et al.
BMC Cancer
|
July 20, 2005
Cancer cell adaptation to chemotherapy
Federica Di Nicolantonio, Stuart J Mercer, Louise A Knight, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Anti-Cancer Drugs
|
July 11, 2003
Heterogeneity of chemosensitivity of esophageal and gastric carcinoma
Stuart J Mercer, Shaw S Somers, Louise A Knight, et al.
Anti-Cancer Drugs
|
August 13, 2002
Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer
Federica Di Nicolantonio, Michael H Neale, Louise A Knight, et al.
Anti-Cancer Drugs
|
October 1, 2004
Ex vivo characterization of XR11576 (MLN576) against ovarian cancer and other solid tumors
Federica Di Nicolantonio, Louise A Knight, Silvana Di Palma, et al.
Anti-Cancer Drugs
|
August 19, 2006
The effect of imatinib mesylate (Glivec) on human tumor-derived cells
Louise A Knight, Federica Di Nicolantonio, Pauline A Whitehouse, et al.
Anti-Cancer Drugs
|
October 1, 2004
Ex vivo reversal of chemoresistance by tariquidar (XR9576)
Federica Di Nicolantonio, Louise A Knight, Sharon Glaysher, et al.
Anti-Cancer Drugs
|
April 23, 2005
Rapid up-regulation of cyclooxygenase-2 by 5-fluorouracil in human solid tumors
Stuart J Mercer, Federica Di Nicolantonio, Louise A Knight, et al.
BMC Cancer
|
July 5, 2003
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
Sanjay Sharma, Michael H Neale, Federica Di Nicolantonio, et al.
BMC Cancer
|
August 29, 2009
Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)
Sharon Glaysher, Dennis Yiannakis, Francis G Gabriel, et al.
BMC Cancer
|
July 20, 2005
Cancer cell adaptation to chemotherapy
Federica Di Nicolantonio, Stuart J Mercer, Louise A Knight, et al.
Page
of 2